Status:
COMPLETED
Comparison Between Platelet Rich Plasma and Corticosteroids for the Treatment of Rotator Cuff Tendinopathy
Lead Sponsor:
Hospital Italiano de Buenos Aires
Conditions:
Shoulder Tendinopaty
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to test if Plateth-rich plasma would provide improved pain relief and function in patients with rotator cuff tendinopathy compared to standard treatment of corticost...
Detailed Description
Rotator cuff tendinopathy represents the most common pathology of the shoulder and is the main reason for outpatient consultation for pathologies related to the shoulder girdle. First-line treatment f...
Eligibility Criteria
Inclusion
- symptomatic rotator cuff tendinopathy (confirmed by ultrasound).
- At least 3 months of failed conservative treatment (decreased activity, anti-inflammatories, kinesiology for at least 3 months before diagnosis).
Exclusion
- Refusal to participate or informed consent
- Previous shoulder surgery,
- Partial or total tears of the rotator cuff,
- Patients with shoulder osteoarthritis
- Advanced fatty infiltration of the rotator cuff muscles
- Systemic or rheumatoid arthritis,
- Uncontrolled diabetes,
- Acute or chronic infections of the shoulder to be operated on
- Ongoing cancer chemotherapy therapies
- Sepsis, septic arthritis, osteomyelitis or other ongoing infectious processes;
- Patients with autoimmune diseases;
- Pregnants
Key Trial Info
Start Date :
September 30 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06150378
Start Date
September 30 2022
End Date
August 31 2023
Last Update
November 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Italiano de Buenos Aires
Ciudad de Buenos Aires, Buenos Aires, Argentina, 1001